Correlation Between DiaMedica Therapeutics and Vaccinex

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both DiaMedica Therapeutics and Vaccinex at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining DiaMedica Therapeutics and Vaccinex into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between DiaMedica Therapeutics and Vaccinex, you can compare the effects of market volatilities on DiaMedica Therapeutics and Vaccinex and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in DiaMedica Therapeutics with a short position of Vaccinex. Check out your portfolio center. Please also check ongoing floating volatility patterns of DiaMedica Therapeutics and Vaccinex.

Diversification Opportunities for DiaMedica Therapeutics and Vaccinex

0.65
  Correlation Coefficient

Poor diversification

The 3 months correlation between DiaMedica and Vaccinex is 0.65. Overlapping area represents the amount of risk that can be diversified away by holding DiaMedica Therapeutics and Vaccinex in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vaccinex and DiaMedica Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on DiaMedica Therapeutics are associated (or correlated) with Vaccinex. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vaccinex has no effect on the direction of DiaMedica Therapeutics i.e., DiaMedica Therapeutics and Vaccinex go up and down completely randomly.

Pair Corralation between DiaMedica Therapeutics and Vaccinex

Given the investment horizon of 90 days DiaMedica Therapeutics is expected to generate 0.82 times more return on investment than Vaccinex. However, DiaMedica Therapeutics is 1.22 times less risky than Vaccinex. It trades about -0.06 of its potential returns per unit of risk. Vaccinex is currently generating about -0.42 per unit of risk. If you would invest  268.00  in DiaMedica Therapeutics on January 24, 2024 and sell it today you would lose (17.00) from holding DiaMedica Therapeutics or give up 6.34% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

DiaMedica Therapeutics  vs.  Vaccinex

 Performance 
       Timeline  
DiaMedica Therapeutics 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days DiaMedica Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, DiaMedica Therapeutics is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders.
Vaccinex 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vaccinex has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in May 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

DiaMedica Therapeutics and Vaccinex Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with DiaMedica Therapeutics and Vaccinex

The main advantage of trading using opposite DiaMedica Therapeutics and Vaccinex positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if DiaMedica Therapeutics position performs unexpectedly, Vaccinex can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaccinex will offset losses from the drop in Vaccinex's long position.
The idea behind DiaMedica Therapeutics and Vaccinex pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Complementary Tools

Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Bonds Directory
Find actively traded corporate debentures issued by US companies
Pair Correlation
Compare performance and examine fundamental relationship between any two equity instruments
Global Correlations
Find global opportunities by holding instruments from different markets
Commodity Directory
Find actively traded commodities issued by global exchanges